CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c
March 8, 2022 4:17 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... MoreCumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c
March 8, 2022 4:17 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More